L-dopa and cardiac arrhythmias.
D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000517:prevention & control; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D011422:Propionates / Q000627:therapeutic use
D006834:Hydrazines; D011422:Propionates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine